2008
DOI: 10.1371/journal.pone.0003301
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants

Abstract: The neurotransmitter serotonin (5-HT) plays an important role in both the peripheral and central nervous systems. The biosynthesis of serotonin is regulated by two rate-limiting enzymes, tryptophan hydroxylase-1 and -2 (TPH1 and TPH2). We used a gene-targeting approach to generate mice with selective and complete elimination of the two known TPH isoforms. This resulted in dramatically reduced central 5-HT levels in Tph2 knockout (TPH2KO) and Tph1/Tph2 double knockout (DKO) mice; and substantially reduced perip… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
188
1
4

Year Published

2010
2010
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 226 publications
(205 citation statements)
references
References 46 publications
12
188
1
4
Order By: Relevance
“…All recent genetic hyposerotonergic models focused on reducing 5-HT production either by targeting the central 5-HT synthesis enzyme, TPH2 (Alenina et al, 2009;Beaulieu et al, 2008;Gutknecht et al, 2008;Savelieva et al, 2008) or by invalidating the transcription factors controlling differentiation of raphe neurons such as pet1 and lmx1B (Dai et al, 2008;Hendricks et al, 2003;Kiyasova et al, 2011;Zhao et al, 2006). The more severe 5-HT depletion observed here (À95%), compared with previous models (À70 to 90%), is likely due to the fact that increased 5-HT degradation, when VMAT2 is absent, affects all sources of 5-HT (eg, produced by TPH1/TPH2).…”
Section: Discussionmentioning
confidence: 99%
“…All recent genetic hyposerotonergic models focused on reducing 5-HT production either by targeting the central 5-HT synthesis enzyme, TPH2 (Alenina et al, 2009;Beaulieu et al, 2008;Gutknecht et al, 2008;Savelieva et al, 2008) or by invalidating the transcription factors controlling differentiation of raphe neurons such as pet1 and lmx1B (Dai et al, 2008;Hendricks et al, 2003;Kiyasova et al, 2011;Zhao et al, 2006). The more severe 5-HT depletion observed here (À95%), compared with previous models (À70 to 90%), is likely due to the fact that increased 5-HT degradation, when VMAT2 is absent, affects all sources of 5-HT (eg, produced by TPH1/TPH2).…”
Section: Discussionmentioning
confidence: 99%
“…The differences in the effect of PCPA on food intake might be due to the differences in the doses of PCPA. Tph1-deficient mice fed a high-fat diet are protected against obesity and insulin resistance via promoting thermogenesis via UCP-1 in brown adipose tissue without affecting food intake [1,2]. On the other hand, Tph2-deficient mice fed a normal diet exhibit decreased food intake and increased energy expenditure, leading to decreases in body weight and fat pad weight [1,3].…”
Section: Discussionmentioning
confidence: 99%
“…Tph1-deficient mice fed a high-fat diet are protected against obesity and insulin resistance via promoting thermogenesis via UCP-1 in brown adipose tissue without affecting food intake [1,2]. On the other hand, Tph2-deficient mice fed a normal diet exhibit decreased food intake and increased energy expenditure, leading to decreases in body weight and fat pad weight [1,3]. Although treatment with PCPA (500 mg/kg), an inhibitor of both Tph1 and Tph2, remarkably decreases brain 5-HT synthesis and serum 5-HT levels [5,6], the A Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression and Circulating FGF21 in Mice Fed A High-Fat Diet lower dose (300 mg/kg) might be less effective on the inhibition of Tph2 in mice fed a high-fat diet.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations